Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Pharmaceutical Development and Technology|December 8, 2000
Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticlesF De Jaeghere, E Allémann, J Feijen, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 28, 2001
Factors and strategies for improving buccal absorption of peptidesF Veuillez, Y N Kalia, Y Jacques, et al.
Journal of Biomedical Materials Research|November 1, 1989
Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery systemF Lescure, R Gurny, E Doelker, et al.
International Journal of Pharmaceutics|November 24, 2001
Permeation of a myristoylated dipeptide across the buccal mucosa: topological distribution and evaluation of tissue integrityF Veuillez, F Falson Rieg, R H Guy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2000
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateF De Jaeghere, E Allémann, F Kubel, et al.
International Journal of Pharmaceutics|June 17, 1999
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retentionO Felt, P Furrer, J M Mayer, et al.
Pharmaceutical Research|July 9, 1999
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptakeF De Jaeghere, E Allémann, J C Leroux, et al.
Journal of Pharmaceutical Sciences|December 1, 1995
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to miceJ C Leroux, R Cozens, J L Roesel, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Failure of a 1-day high-dose quadruple therapy for cure of Helicobacter pylori infectionJ Wermeille, M Cunningham, B Armenian, et al.
Drug Development and Industrial Pharmacy|January 7, 1999
The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nailD Quintanar-Guerrero, A Ganem-Quintanar, P Tapia-Olguín, et al.
Pageof 8